COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

One Clinical Laboratory Now Offering Its COVID-19 Diagnostic Test On Amazon

amazon delivers covid19 tests now
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

Diagnostic SARS-CoV-2 test offers availability on Amazon in new first during pandemic

Throughout the COVID-19 pandemic, access to testing has always been an area of attention. As cases continue to increase throughout most of the country, the need for testing that can be readily accessed has become even more apparent.

One clinical laboratory moved to meet the need for accessible testing by recently offering its COVID-19 diagnostic test through Amazon’s e-commerce platform. DxTerity Diagnostics now offers its DxTerity COVID-19 Saliva at-Home Collection Kit both as individual kits and as sets of 10 kits. This test became available on Amazon Jan. 5, 2021.

The DxTerity COVID-19 Saliva at-Home Collection Kit received an emergency use authorization (EUA) from the US Food and Drug Administration (FDA) in early December. This EUA allowed use of the kit for both symptomatic and asymptomatic testing. A specimen can be collected at home but must be sent to DxTerity’s clinical laboratory in Los Angeles for PCR analysis. DxTerity indicates that results are available within 24 to 72 hours.

Amazon Fast Tracks COVID-19 Test Kits to Consumers

We have focused our efforts on adapting to the challenges of living and working during a pandemic,” said Bob Terbrueggen, PhD, Founder and CEO of DxTerity. “Our new at-home test provides the flexibility and reliability of results for people who are traveling, returning to work or simply want to ensure they can protect themselves and others. Amazon is the perfect partner for expanding access to millions of U.S. customers.”

In addition to the components needed to perform the test, the kits also include prepaid express return shipping labels. The kits also include information about how to register online and receive the necessary physician authorization prior to returning the test. According to the Amazon product description, the test results will be available online and can be easily printed as proof of test results.

While Amazon does not make the number of sales public, the DxTerity test kit was ranked as the No. 1 best seller in the Clinical Diagnostic Test Kits category within 48 hours of being listed on the e-commerce platform and had a five-star rating. Becoming a best seller in its category in such a short period of time indicates that sales for this test kit have grown rapidly.

Time for Clinical Laboratory Services to Become More Consumer Facing?

The availability of COVID-19 testing through Amazon indicates a shift in how patients are able to acquire testing. This shift began in mid-December as tests that could be performed completely at-home, and tests that could be purchased without a prescription both became available. The availability of COVID-19 tests on Amazon will likely continue this trend of increased accessibility of testing directly to patients.

While diagnostic testing for COVID-19 slowly shifts away from clinical laboratories, these changes can be beneficial. The recent success that DxTerity has apparently experienced shows the importance for clinical laboratories to leverage online sales channels and use alternative marketing methods that they may not have previously considered.

By exploring marketing methods that are outside the box, clinical laboratories may find new ways of offering their services during this pandemic.

Caleb Williams

—By Caleb Williams, Editor, COVID-19 STAT

Related Resources:

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group